[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nervgen Pharma Corp (NGEN)

Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Nanogen's is a supplier of molecular diagnostic tests to the medical community and to clinical researchers. They commercialize instruments, consumables, electronic microarrays and reagents through a direct sales force and distributors in North America, Europe and Asia. The Company also provide a highly experienced technical support staff and Field Application Specialists dedicated to helping their customers around the world. The NanoChip(r) Molecular Biology Workstation, the Company's first commercial product, is an automated, multi-purpose instrument primarily used for DNA-based analyses. Researchers in the field of molecular biology and genetics use the platform to study how genes function and to understand the correlation between genetic variation and disease. The NanoChip(r) System can also be used for human identification, important in the forensics field. Their products are ASRs/Applications, NanoChip(r) MBW Workstation, NanoChip(r) 400 System, NanoChip(r) Electronic Microarray and Consumables.

Fiscal Year End Date: 12/31

(Values in U.S. Thousands) Mar, 2026 Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025
Sales 0 0 0 0 0
Sales Growth unch unch unch unch +100.00%
Net Income -1,220 -19,230 -3,020 -6,580 -2,750
Net Income Growth +93.66% -536.76% +54.10% -139.27% +99.97%
(Values in U.S. Thousands) Mar, 2026 Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025
Total Assets 15,140 16,610 9,490 12,240 11,030
Total Assets Growth -8.85% +75.03% -22.47% +10.97% -22.43%
Total Liabilities 11,100 14,120 11,630 12,900 10,060
Total Liabilities Growth -21.39% +21.41% -9.85% +28.23% -18.48%
(Values in U.S. Thousands) Mar, 2026 Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025
Operating Cash Flow -5,980 -13,960 -9,510 -5,630 -2,870
Operating Cash Flow Growth +57.16% -46.79% -68.92% -96.17% +76.65%
Net Cash Flow -4,020 3,440 -4,290 -1,150 -1,950
Change in Net Cash Flow -216.86% +180.19% -273.04% +41.03% -147.68%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.